Akgöl Gür, S. T. Et Al. 2022. Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.1 , 27-33.

Akgöl Gür, S. T., Oral Ahıskalıoğlu, E., Aydın, M. E., Koçak, A. O., Aydin, P., & Ahıskalıoğlu, A., (2022). Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.1, 27-33.

Akgöl Gür, Sultan Et Al. "Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study," EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.1, 27-33, 2022

Akgöl Gür, Sultan T. Et Al. "Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study." EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.1, pp.27-33, 2022

Akgöl Gür, S. T. Et Al. (2022) . "Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study." EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.1, pp.27-33.

@article{article, author={Sultan Tuna AKGÖL GÜR Et Al. }, title={Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study}, journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY}, year=2022, pages={27-33} }